Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU – Get Free Report) traded up 6.7% on Thursday. The stock traded as high as $220.49 and last traded at $224.0610. 84,076 shares changed hands during trading, a decline of 85% from the average session volume of 545,080 shares. The stock had previously closed at $210.02.
Direxion Daily S&P Biotech Bull 3X ETF Stock Performance
The firm’s 50-day simple moving average is $274.94 and its two-hundred day simple moving average is $234.09.
Institutional Trading of Direxion Daily S&P Biotech Bull 3X ETF
Several hedge funds and other institutional investors have recently modified their holdings of the business. Ramsey Quantitative Systems acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3X ETF in the second quarter worth $41,000. Halbert Hargrove Global Advisors LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF during the first quarter valued at $166,000. Valued Retirements Inc. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF during the second quarter valued at $454,000. Finally, Revere Asset Management Inc acquired a new position in Direxion Daily S&P Biotech Bull 3X ETF during the second quarter valued at $666,000.
Direxion Daily S&P Biotech Bull 3X ETF Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3X ETF
- Synopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise Targets
- Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But Up
- Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?
- Failed Breakout in Tech? 3 Sectors Leading the Market Rotation
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3X ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3X ETF and related companies with MarketBeat.com's FREE daily email newsletter.
